Arax Advisory Partners’s Treace Medical Concepts TMCI Stock Holding History

Arax Advisory Partners’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$93.3K	Buy	+23,432	New	+$64.4K	﹤0.01%	2788
2026 Q1	–	Sell	-17	Closed	-$42	–	4318
2025 Q4	$42	Sell	17 -3,547	-100%	-$15.4K	﹤0.01%	3949
2025 Q3	$23.9K	Buy	+3,564	New	+$23.3K	﹤0.01%	2183
2025 Q2	–	Sell	-106	Closed	-$890	–	3191
2025 Q1	$890	Hold	106	–	–	﹤0.01%	2339
2024 Q4	$789	Buy	+106	New	+$709	﹤0.01%	2221

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arax Advisory Partners's TMCI Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 23,432 shares worth $93.3K. The stake represents ﹤0.01% of the portfolio and ranks #2788 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in TMCI as recently as Q4 2025.

Arax Advisory Partners first reported a position in TMCI in Q4 2024 and has held it in 5 quarters since. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

Arax Advisory Partners held 23,432 shares of Treace Medical Concepts worth $93.3K as of Q2 2026.
Treace Medical Concepts was a new Arax Advisory Partners position in Q2 2026.
Treace Medical Concepts made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2788 holding.
Arax Advisory Partners first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 5 quarters since.
116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.